Literature DB >> 18560432

Insights into signaling from the beta2-adrenergic receptor structure.

Martin Audet1, Michel Bouvier.   

Abstract

With more than 800 members, the G protein-coupled receptor family constitutes the largest group of membrane proteins involved in signal transduction. Until the end of last year, high-resolution three-dimensional structures were available for only one of them--the light receptor rhodopsin. Recently the structure of the beta(2)-adrenergic receptor has been obtained, and it revealed interesting differences with the structure of rhodopsin. Analyses of these differences raise important questions about the binding modes of diffusible ligands in the receptor and allow formulation of testable hypotheses about the structural determinants linking drug binding to specific signaling responses. The three-dimensional structure derived from the beta(2)-adrenergic receptor crystal has been used to virtually dock ligands with distinct activities. The different binding modes of these ligands, which correlated with their reported efficacy profiles, suggest that it could be possible to predict the structural determinants of drug signaling efficacies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560432     DOI: 10.1038/nchembio.97

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  32 in total

1.  Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.

Authors:  Prateek Bhatia; Michel Bernier; Mitesh Sanghvi; Ruin Moaddel; Roland Schwarting; Anuradha Ramamoorthy; Irving W Wainer
Journal:  Xenobiotica       Date:  2012-03-08       Impact factor: 1.908

2.  Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.

Authors:  Rajib K Paul; Anuradha Ramamoorthy; Jade Scheers; Robert P Wersto; Lawrence Toll; Lucita Jimenez; Michel Bernier; Irving W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2012-07-09       Impact factor: 4.030

3.  Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors.

Authors:  Hatsumi Yoshiki; Junsuke Uwada; Hidenori Umada; Tadashi Kobayashi; Toshihiro Takahashi; Tomio Yamakawa; Akio Yamaguchi; Osamu Yokoyama; Ikunobu Muramatsu
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

4.  Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.

Authors:  Guo Li; Philip D Mosier; Xianjun Fang; Yan Zhang
Journal:  J Mol Graph Model       Date:  2009-04-19       Impact factor: 2.518

5.  In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation.

Authors:  Milan Senćanski; Ljiljana Dosen-Mićović
Journal:  Protein J       Date:  2014-06       Impact factor: 2.371

6.  Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor.

Authors:  Santiago Vilar; Joel Karpiak; Stefano Costanzi
Journal:  J Comput Chem       Date:  2010-03       Impact factor: 3.376

Review 7.  Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.

Authors:  Srgjan Civciristov; Michelle L Halls
Journal:  Br J Pharmacol       Date:  2019-04-05       Impact factor: 8.739

8.  Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief.

Authors:  Dane D Jensen; TinaMarie Lieu; Michelle L Halls; Nicholas A Veldhuis; Wendy L Imlach; Quynh N Mai; Daniel P Poole; Tim Quach; Luigi Aurelio; Joshua Conner; Carmen Klein Herenbrink; Nicholas Barlow; Jamie S Simpson; Martin J Scanlon; Bimbil Graham; Adam McCluskey; Phillip J Robinson; Virginie Escriou; Romina Nassini; Serena Materazzi; Pierangelo Geppetti; Gareth A Hicks; Macdonald J Christie; Christopher J H Porter; Meritxell Canals; Nigel W Bunnett
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

9.  Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach.

Authors:  Anthony Ivetac; J Andrew McCammon
Journal:  Chem Biol Drug Des       Date:  2010-07-05       Impact factor: 2.817

10.  Docking studies on a refined human beta(2) adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists.

Authors:  Marvin A Soriano-Ursúa; José G Trujillo-Ferrara; Jesús Alvarez-Cedillo; José Correa-Basurto
Journal:  J Mol Model       Date:  2009-07-22       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.